SHC
Sotera Health Co
- Latest sale
- $21.2M
- Aug 17 · Unusual
- Form 4 sales
- 34
- On record
- Form 144 notices
- 0
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleUnusualMar 6 2026
Sold 10M shares at $15.27 ($153M)
Gtcr Co-Invest Xi LP, Director, 10% owner
No 10b5-1 planSold 44% of holdings ($347M position)12.7M shares leftFirst sale on recordFiling
- 2 Form 4 saleUnusualMar 6 same day
Sold 15M shares at $15.27 ($229M)
Warburg Pincus Partners II, L.P., Director, 10% owner
No 10b5-1 planSold 44% of holdings ($521M position)19.1M shares leftFiling
- 3 Form 4 saleUnusualMar 6 same day
Sold 15M shares at $15.27 ($229M)
Warburg Pincus Partners GP LLC, Director, 10% owner
No 10b5-1 planSold 44% of holdings ($521M position)19.1M shares leftFiling
- 4 Form 4 saleUnusualMay 13 +68 days
Sold 12.7M shares at $15.17 ($193M)
Gtcr Fund Xi/c LP, Director, 10% owner
No 10b5-1 planSold 100% of holdings ($193M position)0 shares leftFirst sale on recordFiling
- 5 Form 4 saleUnusualMay 13 same day
Sold 19.1M shares at $15.17 ($290M)
Warburg Pincus XI, L.P., Director, 10% owner
No 10b5-1 planSold 100% of holdings ($290M position)0 shares leftFirst sale on recordFiling
- 6 Form 4 saleUnusualMay 13 same day
Sold 19.1M shares at $15.17 ($290M)
Warburg Pincus (Cayman) XI, L.P., Director, 10% owner
No 10b5-1 planSold 100% of holdings ($290M position)0 shares leftFirst sale on recordFiling
- 7 Form 4 saleUnusualAug 7 +86 days
Sold 150,000 shares at $18.84 ($2.8M)
Rutz Michael P, President of Sterigenics
No 10b5-1 planSold 31% of holdings ($9.1M position)334,279 shares leftFiling
- 8 Form 4 saleUnusualAug 17 +10 days
Sold 1.1M shares at $18.50 ($21.2M)
Petras Michael B. Jr., Executive Chairman
No 10b5-1 planSold 74.2% of holdings ($28.5M position)397,912 shares leftFiling
Every transaction
Loading transactions…
Sales, notices and lockups (34)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Petras Michael B. Jr. | Executive Chairman | Form 4 sale | 1.1M | $21.2M | 74.2% | Unusual | SEC |
| Aug 7, 2026 | Rutz Michael P | President of Sterigenics | Form 4 sale | 150,000 | $2.8M | 31.0% | Unusual | SEC |
| May 13, 2026 | Warburg Pincus (Cayman) XI, L.P. | Director, 10% owner | Form 4 sale | 19.1M | $290M | 100.0% | Unusual | SEC |
| May 13, 2026 | Warburg Pincus XI, L.P. | Director, 10% owner | Form 4 sale | 19.1M | $290M | 100.0% | Unusual | SEC |
| May 13, 2026 | Gtcr Fund Xi/c LP | Director, 10% owner | Form 4 sale | 12.7M | $193M | 100.0% | Unusual | SEC |
| Mar 6, 2026 | Warburg Pincus Partners GP LLC | Director, 10% owner | Form 4 sale | 15M | $229M | 44.0% | Unusual | SEC |
| Mar 6, 2026 | Warburg Pincus Partners II, L.P. | Director, 10% owner | Form 4 sale | 15M | $229M | 44.0% | Unusual | SEC |
| Mar 6, 2026 | Gtcr Co-Invest Xi LP | Director, 10% owner | Form 4 sale | 10M | $153M | 44.0% | Unusual | SEC |
| Dec 8, 2025 | Petras Michael B. Jr. | Chairman & CEO | Form 4 sale | 750,000 | $12.3M | 57.6% | Unusual | SEC |
| Dec 3, 2025 | Warburg Pincus LLC | Director, 10% owner | Form 4 sale | 9.7M | $159M | 22.2% | No plan | SEC |
| Dec 3, 2025 | Warburg Pincus Partners GP LLC | Director, 10% owner | Form 4 sale | 9.7M | $159M | 22.2% | No plan | SEC |
| Dec 3, 2025 | Gtcr Fund Xi/a LP | Director, 10% owner | Form 4 sale | 6.5M | $106M | 22.2% | No plan | SEC |
| Nov 10, 2025 | Warburg Pincus Private Equity XI-C, L.P. | Director, 10% owner | Form 4 sale | 18M | $282M | 29.1% | Unusual | SEC |
| Nov 10, 2025 | Warburg Pincus Partners II, L.P. | Director | Form 4 sale | 18M | $282M | 29.1% | Unusual | SEC |
| Nov 10, 2025 | Gtcr Fund Xi/a LP | Director, 10% owner | Form 4 sale | 12M | $188M | 29.1% | Unusual | SEC |
| Sep 5, 2025 | Warburg Pincus XI-C, LLC | Director, 10% owner | Form 4 sale | 12M | $181M | 16.3% | No plan | SEC |
| Sep 5, 2025 | Warburg Pincus & Co. | Director, 10% owner | Form 4 sale | 12M | $181M | 16.3% | No plan | SEC |
| Sep 5, 2025 | Gtcr Investment Xi LLC | Director, 10% owner | Form 4 sale | 8M | $121M | 16.3% | No plan | SEC |
| Aug 22, 2025 | Rutz Michael P | President of Sterigenics | Form 4 sale | 126,611 | $2.1M | 22.0% | No plan | SEC |
| Sep 6, 2024 | Warburg Pincus Private Equity XI-C, L.P. | Director, 10% owner | Form 4 sale | 15M | $225M | 16.9% | No plan | SEC |
| Sep 6, 2024 | Bull Holdco L.P. | Director, 10% owner | Form 4 sale | 15M | $225M | 16.9% | No plan | SEC |
| Sep 6, 2024 | Gtcr Partners Xi/a&c LP | Director, 10% owner | Form 4 sale | 10M | $150M | 16.9% | No plan | SEC |
| Mar 4, 2024 | Warburg Pincus & Co. | Director, 10% owner | Form 4 sale | 16.6M | $237M | 15.7% | No plan | SEC |
| Mar 4, 2024 | WP Global LLC | Director, 10% owner | Form 4 sale | 16.6M | $237M | 15.7% | No plan | SEC |
| Mar 4, 2024 | Gtcr Partners Xi/a&c LP | Director, 10% owner | Form 4 sale | 11.1M | $158M | 15.7% | No plan | SEC |
| Mar 4, 2024 | Klee Ann R. | Director | Form 4 sale | 5,750 | $82k | 6.2% | No plan | SEC |
| Mar 4, 2024 | Rutz Michael P | President of Sterigenics | Form 4 sale | 83,109 | $1.2M | 13.2% | No plan | SEC |
| Mar 4, 2024 | Petras Michael B. Jr. | Chairman & CEO | Form 4 sale | 1M | $14.4M | 15.5% | No plan | SEC |
| Aug 25, 2021 | Rutz Michael P | President of Sterigenics | Form 4 sale | 67,000 | $1.7M | 10.8% | Plan not stated | SEC |
| Mar 22, 2021 | Klaben Matthew J | SVP, GC and Secretary | Form 4 sale | 41,952 | $1.1M | 11.4% | Plan not stated | SEC |
| Mar 22, 2021 | Petras Michael B. Jr. | Chairman & CEO | Form 4 sale | 817,439 | $21.4M | 11.4% | Plan not stated | SEC |
| Mar 22, 2021 | Warburg Pincus (Cayman) XI, L.P. | Director, 10% owner | Form 4 sale | 13.5M | $353M | 11.4% | Plan not stated | SEC |
| Mar 22, 2021 | Warburg Pincus Partners II, L.P. | Director, 10% owner | Form 4 sale | 13.5M | $353M | 11.4% | Plan not stated | SEC |
| Mar 22, 2021 | Gtcr Co-Invest Xi LP | Director, 10% owner | Form 4 sale | 9M | $235M | 11.4% | Plan not stated | SEC |